DE112004001618D2 - Pharmazeutischer Wirkstoff gegen Tumorerkrankungen - Google Patents

Pharmazeutischer Wirkstoff gegen Tumorerkrankungen

Info

Publication number
DE112004001618D2
DE112004001618D2 DE112004001618T DE112004001618T DE112004001618D2 DE 112004001618 D2 DE112004001618 D2 DE 112004001618D2 DE 112004001618 T DE112004001618 T DE 112004001618T DE 112004001618 T DE112004001618 T DE 112004001618T DE 112004001618 D2 DE112004001618 D2 DE 112004001618D2
Authority
DE
Germany
Prior art keywords
pharmaceutical agent
against tumor
agent against
tumor diseases
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE112004001618T
Other languages
English (en)
Inventor
Dirk Weickmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PATENTPOOL TRUST GMBH, 80331 MUENCHEN, DE
Original Assignee
Toximed GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toximed GmbH filed Critical Toximed GmbH
Priority to DE112004001618T priority Critical patent/DE112004001618D2/de
Publication of DE112004001618D2 publication Critical patent/DE112004001618D2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE112004001618T 2003-06-24 2004-06-21 Pharmazeutischer Wirkstoff gegen Tumorerkrankungen Expired - Fee Related DE112004001618D2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE112004001618T DE112004001618D2 (de) 2003-06-24 2004-06-21 Pharmazeutischer Wirkstoff gegen Tumorerkrankungen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10328251A DE10328251A1 (de) 2003-06-24 2003-06-24 Pharmazeutischer Wirkstoff
DE112004001618T DE112004001618D2 (de) 2003-06-24 2004-06-21 Pharmazeutischer Wirkstoff gegen Tumorerkrankungen
PCT/DE2004/001297 WO2005002604A1 (de) 2003-06-24 2004-06-21 Pharmazeutischer wirkstoff gegen tumorerkrankungen

Publications (1)

Publication Number Publication Date
DE112004001618D2 true DE112004001618D2 (de) 2006-05-11

Family

ID=33520856

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10328251A Withdrawn DE10328251A1 (de) 2003-06-24 2003-06-24 Pharmazeutischer Wirkstoff
DE112004001618T Expired - Fee Related DE112004001618D2 (de) 2003-06-24 2004-06-21 Pharmazeutischer Wirkstoff gegen Tumorerkrankungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10328251A Withdrawn DE10328251A1 (de) 2003-06-24 2003-06-24 Pharmazeutischer Wirkstoff

Country Status (2)

Country Link
DE (2) DE10328251A1 (de)
WO (1) WO2005002604A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006020710D1 (de) 2005-04-22 2011-04-28 Fred Hutchinson Cancer Res Foundation Fluoreszentes chlorotoxinkonjugat und verfahren zur intraoperativen sichtbarmachung von krebs
EP1754486A3 (de) * 2005-08-16 2007-10-31 TOXIMED GmbH Pharmazeutischer Wirkstoff zur Behandlung von Hepatitis, Borreliose und Multipler Sklerose
WO2007060252A2 (de) * 2005-11-28 2007-05-31 Toximed Gmbh Pharmazeutischer wirkstoff zur behandlung von hepatitis, borreliose und multipler sklerose
CA2724384A1 (en) 2008-05-15 2009-11-19 Transmolecular, Inc. Treatment of metastatic tumors
DK2531206T3 (en) 2010-02-04 2017-09-11 Morphotek Inc CHLOROTOXIN POLYPEPTIDES AND CONJUGATES AND USE THEREOF
KR101972173B1 (ko) 2010-05-11 2019-04-24 프레드 헛친슨 켄서 리서치 센터 클로로톡신 변이체, 접합체, 및 이의 사용 방법
CA2913029A1 (en) 2012-12-10 2014-06-19 Fred Hutchinson Cancer Research Center Lipocalin fusion partners
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
WO2017181149A1 (en) 2016-04-15 2017-10-19 Blaze Bioscience, Inc. Methods of treating breast cancer
CN111574587B (zh) * 2020-05-26 2022-08-30 湖南中医药大学 一种蜈蚣提取多肽和在制备抗肿瘤药物方面的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623508B1 (fr) * 1987-11-20 1990-04-20 Commissariat Energie Atomique Proteine basique denommee phospholipase a2 isolee de venin de serpent de la famille des elapides et sa sequence en amino-acides, derives et fragments de ladite proteine, leur procede d'obtention, compositions therapeutiques et agents de diagnostic contenant ladite proteine et/ou ses derives et/ou ses fragments
DE19961141A1 (de) * 1999-12-17 2001-07-26 Mack Gerd R Pharmazeutische Zusammensetzung aus Spinnengiften sowie deren Herstellung und Verwendung zur Behandlung von Tumorerkrankungen
DE10024383B4 (de) * 2000-05-17 2005-07-21 Mack, Gerd R. Mit toxischen Substanzen beladene dendritische Zellen
CN1352108A (zh) * 2000-11-06 2002-06-05 上海博德基因开发有限公司 一种新的多肽——人蝎子短链毒素蛋白18.59和编码这种多肽的多核苷酸
CN1160084C (zh) * 2001-01-18 2004-08-04 中国医学科学院药物研究所 蜈蚣抑癌活性提取物及其提取方法

Also Published As

Publication number Publication date
WO2005002604A1 (de) 2005-01-13
DE10328251A1 (de) 2005-01-13

Similar Documents

Publication Publication Date Title
DE502004003234D1 (de) Gegen missbrauch gesicherte darreichungsform
DE502004004205D1 (de) Gegen missbrauch gesicherte darreichungsform
DE60336485D1 (de) Kombinationstherapie gegen hyperproliferative erkrankungen
DK1545662T3 (da) Lægemiddelindgivelsessystem
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
DE602004017700D1 (de) Transmukosen verabreichung
MA28489B1 (fr) Preparations pharmaceutiques
EE200500035A (et) Personaalne teraapiasektsioon
PT1501534E (pt) Formulacoes farmaceuticas
DK1587478T3 (da) Farmaceutisk sammensætning
HK1095036A1 (en) Virus therapeutic drug
NO20050689L (no) Terapeutisk anvendelse
DK1597171T3 (da) Terapeutisk mikroskum
DE112004001618D2 (de) Pharmazeutischer Wirkstoff gegen Tumorerkrankungen
NO20043576L (no) Pharmaceutical formulation comprising melatonin
DE602004022810D1 (de) Mehrdosis-inhalator
NO20034952D0 (no) Farmasöytiske forbindelser
DK1618130T3 (da) Terapeutisk cancervaccine
DE10393889D2 (de) Medikament-Dosimeter-Kombipackung
DE112004001429D2 (de) Pharmazeutischer Wirkstoff
DK1653963T3 (da) Nasal farmaceutisk sammensætning piribedil
DE112004002232D2 (de) Pharmazeutischer Wirkstoff gegen Brustkrebs
DE112004001629D2 (de) Pharmazeutischer Wirkstoff gegen Prostatakarzinome
ITRM20030053A1 (it) Associazione di farmaci antidiabetici.
ATE399781T1 (de) Aroylsemicarbazidderivate gegen thromboembolische erkrankungen

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: PATENTPOOL TRUST GMBH, 80331 MUENCHEN, DE

8139 Disposal/non-payment of the annual fee